Yoshindo Bags Biocon Biosimilars Rights In First Post-Lupin Deal

Yoshindo To Market Biocon’s Ustekinumab And Denosumab In Japan Once Approved

 
• By Rosalind Rei
  
Vial and syringe laid out on top of a Japanese flag
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business